Released: December 20, 2010
Department of Defense Tuberous Sclerosis Complex Research Program
Anticipated Funding Opportunities for Fiscal Year 2011 (FY11)
The Department of Defense Tuberous Sclerosis Complex Research Program (TSCRP) is administered by the US Army Medical Research and Materiel Command through the Office of Congressionally Directed Medical Research Programs (CDMRP).
Congressional funds for the Fiscal Year 2011 (FY11) TSCRP have NOT yet been appropriated. The TSCRP anticipates offering the following award mechanisms for FY11 pending availability of congressional funds. This pre-announcement should not be construed as an obligation by the government.
- Career Transition Award
Supports TSC researchers during the transition from postdoctoral training to independent positions
- Clinical Trial Award
Supports Phase 0, 1, and 2 clinical trials for TSC
- Exploration - Hypothesis Development Award
Supports the initial exploration of innovative, untested research, and to pursue serendipitous observations
- Idea Development Award
Encourages high impact, innovative research that will drive the TSC research field forward
Details of each award mechanism will be provided in the Program Announcements when released.
Additional notifications will be sent when Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to firstname.lastname@example.org. For more information about the TSCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
- CDMRP Public Affairs